SecBot SecBot
8-K ·Filed May 8, 2026

NVACW

Profusa, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001213900-26-053535
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor Profusa's progress toward meeting the bid price and equity requirements by the July 6, 2026 deadline. A reverse stock split or equity infusion may be necessary. Failure to comply could trigger delisting proceedings, which would be a significant negative catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Profusa received a favorable Nasdaq Hearings Panel decision granting an exception to continue listing on the Nasdaq Capital Market, subject to meeting bid price and stockholders' equity requirements by July 6, 2026. The company transferred from the Global Market to the Capital Market tier. While this avoids immediate delisting, compliance is not guaranteed and failure to meet the conditions could still result in delisting.

Key Facts

  • Nasdaq Hearings Panel granted exception for continued listing on the Nasdaq Capital Market on May 6, 2026.
  • Company must comply with Bid Price Rule (5550(a)(2)) and Equity Rule (5550(b)(2)) by July 6, 2026.
  • Company transferred listing from The Nasdaq Global Market to The Nasdaq Capital Market.
  • No assurance that the company will be able to satisfy all conditions within the specified timeframes.

Financial Impact

No financial figures provided in the filing; the event relates to listing compliance rather than direct financial impact.

Risk Factors

  • Company may fail to meet the bid price or equity requirements by the deadline, leading to delisting.
  • Any significant adverse event during the exception period could cause the Panel to reconsider the exception.
  • Potential need for dilutive financing or reverse stock split to regain compliance.

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-053535
Document: ea028959701ex99-1.htm0001213900-26-053535
Document: 0001213900-26-053535-index-headers.html0001213900-26-053535
Document: 0001213900-26-053535-index.html0001213900-26-053535
Document: 0001213900-26-053535.txt0001213900-26-053535
10 reports for NVACW
Performance horizon
Filters
Rows
Reports for NVACW — sortable, filterable
TypeNow
Jun 8, 2026
20w ago
8-K
BEARISH ★ 6/10
—awaiting T+20——
May 26, 2026
21w ago
8-K
BULLISH ★ 5/10
—awaiting T+20——
May 15, 2026
23w ago
8-K
NEUTRAL ★ 4/10
—awaiting T+20——
May 8, 2026
24w ago
8-K
NEUTRAL ★ 4/10
—awaiting T+20——
May 1, 2026
25w ago
S-1/A
BEARISH ★ 8/10
—awaiting T+20——
Apr 29, 2026
25w ago
8-K
BEARISH ★ 7/10
—awaiting T+20——
Apr 28, 2026
26w ago
S-1
BEARISH ★ 8/10
—awaiting T+20——
Apr 27, 2026
26w ago
8-K
MIXED ★ 5/10
—awaiting T+20——
Apr 24, 2026
26w ago
8-K
BEARISH ★ 7/10
—awaiting T+20——
Apr 6, 2026
29w ago
8-K
MIXED ★ 6/10
—awaiting T+20——
Showing 10 of 10

US Market Status

Market Open — Closes in 5h 8m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 8, 2026